The growing field of targeted treatment relies heavily on recombinant mediator technology, and a thorough understanding of individual profiles is essential for refining experimental design and therapeutic efficacy. https://socialtechnet.com/story6484120/analyzing-recombinant-mediator-profiles-il-1a-il-1b-il-2-and-il-3